Together, our results thus support the existence of a OB AON LH PVN circuit (Supplementary Fig
What is patient satisfaction and what is its financial impact? Relias
Saxenda, the second to be approved, only achieved middling weight-management results for a large share of those who took it, and physicians were reticent to prescribe weight-loss medications after the disastrous effects of drugs such as fen-phen were revealed in the late 90s
The main safety concern involves compounded GLP-1 medications, which lack FDA oversight for quality and consistency
Strategy 4: Pace Your Weight Loss Research consistently shows that slower weight loss significantly reduces hair shedding risk
Tirzepatide (Mounjaro, Zepbound) Tirzepatide activates both GLP-1 and GIP receptors, providing stronger weight loss effects than semaglutide in head-to-head trials